Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Competitive bidding begins

This article was originally published in The Gray Sheet

Executive Summary

CMS begins taking bids Oct. 21 for durable medical equipment, prosthetics, orthotics and supplies in nine metropolitan areas under the Medicare Competitive Bidding Program round-one rebid process. The program covers Cincinnati; Cleveland; Charlotte, N.C. and surroundings; Dallas; Kansas City, Mo., and Kansas City, Kansas; Miami/Ft. Lauderdale; Orlando; Pittsburgh; and Riverside/San Bernardino/Ontario, Calif. Negative pressure wound therapy items and Group 3 complex rehabilitative wheelchairs are excluded from the program in the rebid. The rest of the items will be the same as included in the first round-one bid, which was implemented July 1, 2008, but delayed two weeks later under the Medicare Improvements for Patients and Providers Act of 2008 (1"The Gray Sheet" Jan. 19, 2009). Items in this round encompass nine product categories, including oxygen and oxygen equipment, Group 2 complex rehabilitative wheelchairs and mail-order replacement diabetic supplies. Bidding in this round closes Dec. 20. Round two bidding, for 70 additional service areas, is slated for 2011
Advertisement

Related Content

Rule Calls For Durable Medical Equipment Competitive Rebids In 2009
Rule Calls For Durable Medical Equipment Competitive Rebids In 2009

Topics

Advertisement
UsernamePublicRestriction

Register

MT028076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel